Supporting Cancer Research
|
Events
|
Resource Library
|
Contact Us
Our Company
Our Products and
Services
Our Partners
For Investors
For Media
Careers
Corporate Social
Responsibility
For Investors
Investor Home
Why Invest?
Investor Presentation
Investor Kit
Financials
Quarterly Results
Annual Report
Archived Annual Reports
Financial Summary
SEDAR
EDGAR
Investor Kit
Report Request Form
Stock Info
Stock Quote
Historical Price Lookup
Investment Calculator
Dividend Information
Analyst Coverage
Events
2012
2011
2010
Industry Events
News Releases
2012
2011
2010
2009
2008
2007
Corporate Governance
Corporate Governance
Annual Report
Proxy Circular
Directors and Management
Board of Directors
Executive Management Team
Compensation of Directors
Board and Committee Charters
Guidelines & Practices
Disclosure Required by Section 303A.11 of NYSE
Global Business Practice Standards
FAQ
Contact IR
E-mail Alerts
Report Request Form
Home
|
News Releases 2007
12-05-2007
MDS Nordion Provides Update to Customers on AECL's Medical Isotope Supply Disruption
11-30-2007
MDS Nordion Provides Update to Medical Isotope Customers
11-29-2007
MDS Nordion Divests Non Strategic Product Lines
10-19-2007
MDS Nordion signs 17-year contract with Rosenergoatom
06-04-2007
MDS Nordion and University of Ottawa Heart Institute Launch Molecular Imaging Centre of Excellence to Advance Innovative Cardiology Research
04-04-2007
MDS Nordion Enters Collaboration Agreement with Avid Radiopharmaceuticals on Imaging Compounds for Alzheimer's Disease
03-09-2007
MDS Nordion : Letter to Industry Colleagues
03-01-2007
MDS Nordion to Expand Facility to Meet Growing Demand for Medical Imaging Agent in Europe
02-08-2007
MDS Nordion Establishes European Centers of Excellence for Innovative Liver Cancer Therapy
01-17-2007
First Patients in India Receive Innovative Treatment for Primary Liver Cancer
01-10-2007
Expanded use for TheraSphere
®
offers physicians an innovative alternative to traditional liver cancer therapies
